The summary data were downloaded from the following website (<http://www.reprogen.org>). Other data can be downloaded from <http://cnsgenomics.com/software/smr/#DataResource>.

Introduction {#sec005}
============

Menarche is the first menstrual cycle and signals the possibility of fertility. An early onset of menarche is associated with risks for obesity, type 2 diabetes, cardiovascular disease, breast cancer and all-cause mortality \[[@pone.0213953.ref001]\]. Menopause is defined as the permanent cessation of menses due to the loss of ovarian follicular activity. Younger age at natural menopause (ANM) is associated with low risk of breast cancer and ovarian cancer, but higher risks of osteoporosis, cardiovascular disease and type 2 diabetes \[[@pone.0213953.ref001]\]. A Mendelian randomization study has found that later ANM causally increased the risk of breast cancer \[[@pone.0213953.ref002]\]. These two traits also mark the beginning and the end of a woman's reproductive life \[[@pone.0213953.ref003]\].

Genome-wide association studies (GWAS) are capable of identifying the association between target phenotypes and millions of genetic variants. GWAS of age at menarche (AAM) identified 106 loci containing 389 independent signals \[[@pone.0213953.ref004]\]. GWAS of ANM has successfully identified dozens of significantly associated loci \[[@pone.0213953.ref002], [@pone.0213953.ref005], [@pone.0213953.ref006]\]. Most of these loci encode proteins that appear to be involved in DNA repair, immune response and breast cancer processes \[[@pone.0213953.ref002], [@pone.0213953.ref005]\]. However, GWAS can only identify those SNPs strongly associated with the target phenotypes, without pinpointing the target genes and the underlying biological mechanism. For example, the largest GWAS of ANM identified 44 loci containing at least one common variant significantly associated with ANM \[[@pone.0213953.ref002]\]. However, the significant SNPs in 21 loci were annotated to more than one gene in each locus. It suggested that the specific causal genes remain mostly unidentified.

A large number of genetic variants influences the target phenotypes by causal regulatory effect rather than directly influencing the structure of the protein \[[@pone.0213953.ref007]\]. Expression quantitative trait locus (eQTL), which is a genetic variant influencing a target gene's expression, is often used to explain the underlying biological mechanism of significant SNPs identified by GWAS. Previous studies have suggested that in the significant loci, those SNPs which were also eQTLs were more likely to be functional SNPs \[[@pone.0213953.ref008]\]. Zhu et al. proposed a summary-based Mendelian randomization (SMR) analysis to combine GWAS and eQTL data into a single analysis \[[@pone.0213953.ref007]\]. SMR integrates GWAS and eQTL data identified from the whole blood tissue to identify potential functionally relevant genes at the significant loci identified in GWAS. Previous studies have shown that whole blood can be a proxy of relevant tissues for various phenotypes and diseases \[[@pone.0213953.ref007], [@pone.0213953.ref009]\].

In this study, we identified genes whose expression levels were associated with AAM or ANM due to pleiotropy or causality, by integrating ANM GWAS data with eQTL data. We conducted a colocalization analysis to identify significant SNPs causally associated with both phenotypes.

Materials and methods {#sec006}
=====================

AAM GWAS summary dataset {#sec007}
------------------------

The largest AAM GWAS meta-analysis contained data from ReproGen consortium studies UK Biobank and 23andMe study. Using the 1000 Genomes Project--imputed genotype data in up to \~370,000 European women, 389 independent signals (P \< 5 × 10^−8^) were identified for age at menarche \[[@pone.0213953.ref004]\]. The summary data were downloaded from the following website ([http://www.reprogen.org](http://www.reprogen.org/)).

ANM GWAS summary dataset {#sec008}
------------------------

The largest-scale GWAS meta-analysis summary data of ANM was used in this study \[[@pone.0213953.ref002]\]. The GWAS meta-analysis conducted with a total sample of 69,360 individuals of European descent from 21 studies identified 44 significant loci. SNPs with the minor allele frequency (MAF) no less than 0.01 and the imputation quality larger than 0.4 were included in the meta-analysis. The summary data were downloaded from the following website ([http://www.reprogen.org](http://www.reprogen.org/)).

eQTL dataset {#sec009}
------------

Because the Westra eQTL data \[[@pone.0213953.ref009]\] had a low coverage of human genes (5,967), in this study we used the Consortium for the Architecture of Gene Expression (CAGE) eQTL data which contained 11,829 unique probes to perform the SMR test \[[@pone.0213953.ref010]\]. The CAGE study was performed to investigate the genetic architecture of gene expression in peripheral blood in 2,765 European individuals \[[@pone.0213953.ref010]\]. We set the p-value threshold to be 5×10^−8^ to select the top associated eQTL for the SMR test. After removing those probes where the p-value of the top eQTL was larger than 5×10^−8^, there were 8,144 probes left in the eQTL summary data. The binary summary data can be downloaded from <http://cnsgenomics.com/software/smr/#DataResource>.

Genetic correlation {#sec010}
-------------------

We used stratified linkage disequilibrium score regression (LDSC) to estimate the genetic correlation between AAM and ANM using GWAS summary statistics \[[@pone.0213953.ref011]\].

SMR analysis {#sec011}
------------

The method of SMR was fully described in the previous paper \[[@pone.0213953.ref007]\]. In this study, the phenotypic trait is the outcome (Y), gene expression is the exposure (X), and the top cis-eQTL that is strongly associated with gene expression is used as the instrumental variable (Z). SMR method assumes that the eQTL has an effect on the trait through the gene expression. In brief, there were three models including causality (Z - \> X - \> Y), pleiotropy (Z - \> X and Z - \> Y) and linkage (Z~1~ - \> X, Z~2~ - \> Y, and Z~1~ and Z~2~ are two variants in linkage disequilibrium (LD) in the cis-eQTL region). Since the SMR analysis assumes that the instrument (top cis-eQTL) has a strong effect on the exposure (gene's expression level), only probes with at least one cis-eQTL at P~eQTL~ (a p-value from the eQTL study indicating the significance of the eQTL associated with the gene expression) smaller than 5×10^−8^ in the cis-eQTL region were included in the eQTL summary data (hg19) \[[@pone.0213953.ref007]\]. We excluded cis-eQTL with MAF \< 0.01 and cis-eQTL in the MHC region because of the complexity of LD patterns in this region \[[@pone.0213953.ref007]\]. In this study, we tried to identify those genes with causal or pleiotropic effect on AAM or ANM.

To distinguish the causality and pleiotropy models from the linkage model, we conducted the heterogeneity in dependent instruments (HEIDI) test \[[@pone.0213953.ref007]\]. The HEIDI test considers the pattern of associations using all the SNPs that are significantly associated with gene expression (eQTLs) in the cis-eQTL region (±500kb from the center of the gene probe). The null hypothesis is that there is a single variant affecting trait and gene expression (pleiotropy or causality). The alternative hypothesis is that gene expression and trait are affected by two distinct variants. Under Hardy-Weinberg equilibrium and linkage disequilibrium (LD), b~XY~ (the effect of the gene expression on the trait) estimated at the top associated cis-eQTL (b~XY(top)~) will be equal to that estimated at any of the cis-SNPs in LD that is associated with gene expression. If we define d~i~ = bXY(i)−b~XY(top)~, with b~XY(i)~ being the b~XY~ value of the i-th cis-eQTL, then it is equal to test whether d~i~ = 0. If the number of significant eQTL (excluding the top cis-eQTL) in the cis-eQTL region is m, then we can have a normal vector z~d(i)~ = {z~d(1)~,z~d(2)~,...,z~d(m)~}, where $z_{d(i)} = \frac{d_{i}}{\sqrt{var\left( d_{i} \right)}}$. To test against d~i~ = 0, we can use the HEIDI test statistic *T*~*HEIDI*~ = z~d~Iz~d~^T^, with z~d~^T^ being the transposed vector of z~d~, and I being an identity matrix, as it is estimated as $T_{HEIDI} = {\sum_{i}^{m}z_{d(i)}^{2}}$ \[[@pone.0213953.ref007]\]. SNPs in the cis-eQTL region with a P~eQTL~ \> 1.6 × 10^−3^ (equivalent to χ^2^ \< 10) were removed to avoid weak instrumental variables according to the original paper \[[@pone.0213953.ref007]\]. We used P~HEIDI~ \> 0.05 to exclude those genes belonging to the linkage model \[[@pone.0213953.ref007]\]. The SMR software was downloaded from <http://cnsgenomics.com/software/smr/#Download>.

It was impossible to give a causal conclusion based on only one instrumental variable. In Mendelian randomization studies, multiple uncorrelated instrumental variables (for example, the trans-eQTLs and/or uncorrelated cis-eQTLs) were needed to identify the causality. However, multiple uncorrelated instrumental variables (IVs) were not available in the CAGE eQTL data. In this study, we did not distinguish the causality model from the pleiotropy model.

Colocalization analysis {#sec012}
-----------------------

Colocalization analysis was used to identify the genetic variants affecting both phenotypes. The method was detailed in the previous paper \[[@pone.0213953.ref012]\]. In brief, the method based on a hierarchical Bayesian model which can be used to find the region containing a variant that influences both phenotypes. According to the previous paper, there were four models that a given genomic region either 1) contains a genetic variant that influences the first trait, 2) contains a genetic variant that influences the second trait, 3) contains a genetic variant that influences both traits, or 4) contains both a genetic variant that influences the first trait and a separate genetic variant that influences the second trait \[[@pone.0213953.ref012]\]. It estimated the posterior probability of each model. The threshold of posterior probability equal to 0.9 was used to control the false discovery rate at level 0.1 \[[@pone.0213953.ref012]\].

Results {#sec013}
=======

The genetic correlation between AAM and ANM was 0.0079 (p-value = 0.0032). The genome-wide significant level for SMR analysis was P~smr~ \< 6.14×10^−6^ (0.05/8,144, Bonferroni test). We identified 98 gene-trait associations with P~smr~ \< 6.14×10^−6^. After the application of the HEIDI test, this reduced to 54 gene-trait associations (P~HEIDI~ \> 0.05). Those genes which did not pass the HEIDI test may be associated with AAM or ANM due to linkage.

We identified 31 genes associated with AAM ([Table 1](#pone.0213953.t001){ref-type="table"}) and 24 genes associated with ANM due to pleiotropy or causality ([Table 2](#pone.0213953.t002){ref-type="table"}). Three (ATP1B3, NAAA, and GRTP1) among of the 31 genes associated with AAM can be considered as novel genes, i.e. no previously identified SNP reported as genome-wide significant in the primary GWAS paper in the cis-eQTL region of the probes ([Fig 1](#pone.0213953.g001){ref-type="fig"}). Among the 24 genes associated with ANM, seven genes (MSH6, TLK1, SYCP2L, BRCA1, PGAP3, DIDO1, and DDX17) were previously annotated to be responsible for the association based on distance, biological function, eQTL effect and non-synonymous SNP in high LD. We also identified 6 new genes (AK125462, MSL2, CLSTN3, TRAPPC2L, DDX5, and CPNE1) where there was no significant SNP (p \< 5×10^−8^) in the cis-eQTL region of the probes ([Fig 2](#pone.0213953.g002){ref-type="fig"}). C17orf46 was the only gene identified to be associated with both phenotypes.

![The SMR plots of novel genes associated with AAM.\
(A) The SMR result at ATP1B3 locus. (B) The SMR result at NAAA locus. (C) The SMR result at GRTP1 locus. In the top plot, black dots represent the p values for the SNPs from the latest GWAS meta-analysis for AAM (Y-axis), diamonds represent the p values for probes from the SMR test. In the bottom plot, the eQTL p values of the SNPs were from the eQTL study (Y-axis).](pone.0213953.g001){#pone.0213953.g001}

![The SMR plots of novel genes associated with ANM.\
(A) The SMR result at AK125462 locus. (B) The SMR result at MSL2 locus. (C) The SMR result at CLSTN3 locus. (D) The SMR result at TRAPPC2L locus. (E) The SMR result at DDX5 locus. (F) The SMR result at CPNE1 locus. In the top plot, black dots represent the p values for the SNPs from the latest GWAS meta-analysis for AAM (Y-axis), diamonds represent the p values for probes from the SMR test. In the bottom plot, the eQTL p values of the SNPs were from the eQTL study (Y-axis).](pone.0213953.g002){#pone.0213953.g002}

10.1371/journal.pone.0213953.t001

###### Genes identified by SMR analysis for AAM.

![](pone.0213953.t001){#pone.0213953.t001g}

  probeID        Chr   Gene       topSNP       topSNP_bp   p_GWAS     p_eQTL      b_SMR    p_SMR       p_HEIDI   Gene[^a^](#t001fn002){ref-type="table-fn"}   Gene[^c^](#t001fn004){ref-type="table-fn"}
  -------------- ----- ---------- ------------ ----------- ---------- ----------- -------- ----------- --------- -------------------------------------------- --------------------------------------------
  ILMN_1869109   1     NUCKS1     rs823094     205689807   4.83E-08   3.39E-38    -0.064   8.24E-07    0.24      NUCKS1                                       NUCKS1/ RAB7L1/ PM20D1
  ILMN_1765061   2     OXER1      rs12617390   42985395    1.25E-07   4.61E-31    0.073    2.45E-06    0.46      OXER1                                        OXER1
  ILMN_1659854   2     PRPF40A    rs7592669    153550668   7.80E-12   2.08E-10    0.16     3.75E-06    0.98      PRPF40A                                      NA
  ILMN_1783304   3     ATP1B3     rs2115935    141616198   0.5        3.82E-23    -0.010   3.82E-23    1.00      NEW[^b^](#t001fn003){ref-type="table-fn"}    NA
  ILMN_1732452   3     MAPKAPK3   rs13096264   50678280    3.26E-10   5.31E-47    -0.070   1.37E-08    1.00      DOCK3                                        MAPKAPK3
  ILMN_1752631   3     CGGBP1     rs9814057    88214472    4.67E-09   1.86E-107   -0.043   2.75E-08    0.98      C3orf38                                      CGGBP1
  ILMN_1744471   3     ZNF654     rs7653652    88189341    3.56E-09   8.55E-79    -0.050   3.17E-08    0.95      C3orf38                                      CGGBP1
  ILMN_2285568   4     NAAA       rs4859572    76857388    0.5        1.90E-146   0.0040   1.90E-146   0.51      NEW[^b^](#t001fn003){ref-type="table-fn"}    NA
  ILMN_1749409   6     HLA-F      rs3870968    29647149    1.16E-09   4.51E-37    0.073    6.40E-08    0.09      HCG4                                         NA
  ILMN_1697309   7     NCF1       rs2267812    74138121    1.87E-13   8.72E-42    -0.088   1.54E-10    0.13      GTF2I                                        NA
  ILMN_2112988   7     NCF1C      rs2267812    74138121    1.87E-13   2.41E-31    -0.10    7.10E-10    0.16      GTF2I                                        NA
  ILMN_2083333   7     PMS2L5     rs3846966    74113141    3.23E-12   3.35E-22    -0.11    2.10E-08    0.09      GTF2I                                        NA
  ILMN_1788384   9     C9orf5     rs12686736   111888739   1.45E-14   1.59E-74    -0.062   2.24E-12    0.13      TMEM245                                      TMEM245
  ILMN_2191929   9     C9orf6     rs874864     111728718   5.66E-13   6.02E-24    0.11     6.09E-09    0.11      TMEM245                                      TMEM245
  ILMN_2163306   9     FAM120A    rs1055710    96214928    1.35E-08   2.83E-15    0.12     5.46E-06    0.86      FAM120A                                      NA
  ILMN_2377829   10    NANOS1     rs671736     120811073   4.38E-08   3.49E-88    -0.043   2.37E-07    0.16      EIF3A                                        NANOS1
  ILMN_1665964   11    GAB2       rs901105     77924607    3.51E-13   8.11E-13    0.16     3.99E-07    0.78      GAB2                                         GAB2
  ILMN_1767642   11    C11orf46   rs7926666    30363101    6.58E-08   8.15E-34    -0.066   1.31E-06    0.24      C11orf46                                     C11ORF46
  ILMN_2094106   11    HSD17B12   rs7118906    43817320    3.67E-07   1.07E-82    0.040    1.62E-06    0.05      MIR129-2                                     HSD17B12
  ILMN_1695585   12    RPS26      rs1131017    56435929    3.25E-07   0           0.019    7.70E-07    0.36      RPS26                                        NA
  ILMN_2142353   13    GRTP1      rs4907616    114008744   0.5        1.52E-12    0.016    1.52E-12    0.87      NEW[^b^](#t001fn003){ref-type="table-fn"}    NA
  ILMN_1727271   14    WARS       rs1570305    100808155   2.63E-09   1.08E-226   0.029    9.21E-09    0.11      WDR25                                        WARS
  ILMN_2080760   15    SNX22      rs12102207   64607472    2.15E-10   9.29E-17    -0.12    5.98E-07    0.49      CSNK1G1                                      TRIP4
  ILMN_1724406   16    INO80E     rs4787491    30015337    6.98E-13   4.48E-18    0.13     4.14E-08    0.06      TBX6                                         MVP/ KCTD13/ INO80E
  ILMN_1717565   16    CLEC18A    rs3748388    69974448    3.75E-14   3.89E-09    0.20     3.71E-06    0.10      NFAT5                                        WWP2
  ILMN_2056687   17    C17orf56   rs1048775    79202329    5.78E-08   4.60E-38    0.066    9.46E-07    0.19      SLC38A10                                     C17ORF56/ AZI1
  ILMN_1707391   17    STXBP4     rs244293     53230722    2.26E-13   4.87E-09    0.20     5.35E-06    0.93      STXBP4                                       NA
  ILMN_1715968   19    MLL4       rs17638853   36234652    1.89E-09   1.41E-12    -0.12    5.89E-06    0.23      KMT2B                                        COX6B1/ SNX26
  ILMN_1776188   20    MAP1LC3A   rs4564863    33179367    1.94E-08   8.12E-110   -0.038   9.50E-08    0.25      GGT7                                         MAP1LC3A
  ILMN_1781225   22    C22orf27   rs5753373    31283719    1.42E-11   1.76E-78    0.057    3.57E-10    0.95      OSBP2                                        MORC2/ FLJ35801/ OSBP2
  ILMN_2103591   22    MORC2      rs7284474    31390187    6.47E-11   7.08E-24    -0.11    5.99E-08    0.10      OSBP2                                        MORC2/ FLJ35801/ OSBP2

topSNP was the most significant SNP in the cis-region of the probe. topSNP_bp was the position of the most significant SNP. p_GWAS was p-value from GWAS. p_eQTL was p-value from eQTL study. b_smr was effect size from SMR test. p_smr was p-value from SMR test. p_HEIDI was p-value from HEIDI test.

a: These genes were annotated by previous AAM GWAS.

b: These genes were considered as novel genes. No SNP in the cis-eQTL region of the probes was identified to be significantly associated with AAM according to the primary GWAS.

c: Genes were identified by previous SMR analysis in the same locus. NA meant that no gene was identified in this locus.

10.1371/journal.pone.0213953.t002

###### Genes identified by SMR analysis for ANM.

![](pone.0213953.t002){#pone.0213953.t002g}

  probeID        Chr   Gene       topSNP_bp   topSNP       p_GWAS     p_eQTL      b_SMR   p_SMR      p_HEIDI    Gene[^a^](#t002fn002){ref-type="table-fn"}
  -------------- ----- ---------- ----------- ------------ ---------- ----------- ------- ---------- ---------- --------------------------------------------
  ILMN_1810915   1     FAAH       46747301    rs12142240   6.60E-09   5.31E-28    0.38    2.24E-08   5.54E-02   RAD54L
  ILMN_1716004   1     NSUN4      46806703    rs10489769   8.20E-08   9.38E-77    0.21    1.14E-08   3.25E-01   RAD54L
  ILMN_1793461   1     AK125462   149848885   rs1260246    1.60E-06   3.92E-79    0.21    5.91E-06   9.53E-01   NEW^b^
  ILMN_1732810   2     SNX17      27644464    rs1728922    1.20E-14   5.12E-23    0.60    5.06E-10   6.58E-02   BRE / GTF3C2/ EIFB4
  ILMN_1670096   2     NRBP1      27584666    rs7586601    2.30E-14   1.59E-10    0.94    5.85E-07   1.82E-01   BRE / GTF3C2/ EIFB4
  ILMN_1729051   2     MSH6       48018081    rs1800932    3.20E-11   4.44E-47    0.30    1.34E-07   3.86E-01   MSH6
  ILMN_1811029   2     TLK1       171871997   rs13004273   5.90E-17   1.67E-10    1.01    1.89E-07   5.00E-01   TLK1 / GAD1
  ILMN_1788053   2     SLC25A12   172704291   rs4668414    2.30E-07   8.11E-21    -0.42   4.40E-07   2.27E-01   TLK1 / GAD1
  ILMN_1766859   3     MSL2       136518670   rs13433683   1.10E-05   2.00E-44    0.23    3.08E-07   9.18E-01   NEW[^b^](#t002fn003){ref-type="table-fn"}
  ILMN_1779743   6     SYCP2L     10895260    rs6899676    2.20E-19   3.03E-10    1.08    1.14E-06   6.02E-01   SYCP2L / MAK
  ILMN_1798804   6     SRPK1      35809776    rs17705020   1.70E-06   7.09E-34    0.28    3.79E-06   5.41E-02   MSH5 / HLA
  ILMN_1767642   11    C11orf46   30363101    rs7926666    1.90E-11   8.15E-34    -0.39   1.99E-08   6.12E-02   FSHB
  ILMN_1734021   12    CLSTN3     7284301     rs2167285    1.20E-06   9.69E-20    -0.44   2.53E-06   5.06E-02   NEW[^b^](#t002fn003){ref-type="table-fn"}
  ILMN_1654421   12    MPHOSPH9   123634122   rs884548     6.80E-07   2.39E-18    -0.44   7.57E-07   5.77E-01   KNTC1 / PITPNM
  ILMN_1859908   16    TRAPPC2L   88927221    rs3826061    2.80E-06   3.93E-198   -0.11   8.13E-07   7.80E-02   NEW[^b^](#t002fn003){ref-type="table-fn"}
  ILMN_1805636   17    PGAP3      37833035    rs2941506    2.00E-09   2.98E-57    -0.28   1.75E-09   6.23E-01   STARD3/ PGAP3/ CDK12
  ILMN_2311089   17    BRCA1      41215825    rs3092994    2.80E-10   1.18E-66    0.28    8.81E-11   1.58E-01   BRCA1
  ILMN_1700690   17    VAT1       41215825    rs3092994    2.80E-10   4.47E-15    -0.61   1.77E-07   3.21E-01   BRCA1
  ILMN_1805344   17    DDX5       62502435    rs1991401    9.60E-07   2.73E-84    0.22    9.84E-09   8.01E-02   NEW[^b^](#t002fn003){ref-type="table-fn"}
  ILMN_1802053   19    ZNF91      23545004    rs296092     1.50E-06   5.82E-118   0.15    8.78E-08   6.96E-01   ZNF729
  ILMN_2307025   20    CPNE1      34221155    rs6060524    1.40E-05   5.28E-244   0.10    7.62E-07   1.00E+00   NEW[^b^](#t002fn003){ref-type="table-fn"}
  ILMN_1812934   20    DIDO1      61558775    rs910831     7.10E-10   2.65E-16    0.55    3.19E-08   4.00E-01   SLCO4A1 / DIDO1
  ILMN_2371590   22    DDX17      39021522    rs5757187    1.30E-12   1.88E-28    -0.49   9.01E-11   1.00E-01   DMC1/ DDX17
  ILMN_1668535   22    JOSD1      39065172    rs3788545    3.60E-12   3.06E-12    0.78    1.46E-07   7.48E-01   DMC1 / DDX17

topSNP was the most significant SNP in the cis-region of the probe. topSNP_bp was the position of the most significant SNP. p_GWAS was p-value from GWAS. p_eQTL was p-value from the eQTL study. b_smr was effect size from SMR test. p_smr was p-value from SMR test. p_HEIDI was p-value from HEIDI test.

a: These genes were annotated by previous ANM GWAS.

b: These genes were considered as novel genes. No SNP in the cis-eQTL region of the probes was identified to be significantly associated with ANM according to the primary GWAS.

To identify more pleiotropic SNPs and genes associated with both phenotypes, we conducted a colocalization analysis. One region was identified to contain a variant influencing both phenotypes with the posterior probability of 0.92 ([Table 3](#pone.0213953.t003){ref-type="table"}). Thirteen regions were considered to influence the two phenotypes through different variants ([Table 3](#pone.0213953.t003){ref-type="table"}). rs3136249, with the largest posterior probability (0.37), was considered to be the causal SNP influencing both phenotypes.

10.1371/journal.pone.0213953.t003

###### Colocalization analysis results of AAM and ANM.
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  chunk   chr     st          sp          PPA_3     PPA_4
  ------- ------- ----------- ----------- --------- -------
  162     chr2    47318990    48212562    0.92      0.064
  1419    chr15   88370262    90473690    2.5E-17   1.00
  1579    chr19   614967      2098015     1.1E-08   1.00
  360     chr3    135458294   137370076   4.1E-06   1.00
  653     chr6    28918936    29737846    3.3E-05   1.00
  799     chr7    92500845    93966036    5.4E-05   1.00
  1637    chr20   32819871    34960201    6.7E-05   0.99
  656     chr6    31572333    32682429    3.5E-03   0.97
  655     chr6    30798697    31568469    6.1E-04   0.94
  1682    chr22   19913726    22355640    4.0E-04   0.94
  128     chr1    241582668   242070731   2.5E-04   0.93
  1644    chr20   42680811    44838112    1.9E-03   0.93
  1693    chr22   37570784    39306630    3.0E-04   0.92
  1213    chr12   55665948    57543572    3.7E-04   0.91

Chunk was the internal numerical identifier for the segment. chr: chromosome. st: star position. sp: end position. PPA_3 was the posterior probability of model 3. PPA_4 was the posterior probability of model 4.

Discussion {#sec014}
==========

In this study, we identified 31 genes whose expressions were associated with AAM and 24 genes whose expressions were associated with ANM due to pleiotropy or causality. In total, we identified 9 new genes where there was no significant SNP in the cis-eQTL region of the gene probe. Many of these genes participated in DNA repair, immune response, and breast cancer process \[[@pone.0213953.ref002], [@pone.0213953.ref005]\]. C17orf46 was identified to be associated with both phenotypes by integrating GWAS and eQTLs data. We also found one region with a pleiotropic effect influencing two phenotypes through the colocalization analysis.

Although the previous study performed the SMR analysis with Westra eQTL data which had a low coverage of human genes (5,967) compared to CAGE eQTL data (8,144). Thus the previous study may omit many potential genes. Eleven genes of the 31 genes associated with AAM were successfully identified by using CAGE eQTL data ([Table 1](#pone.0213953.t001){ref-type="table"}).

SMR demonstrated that it was useful to prioritize genes associated with AAM or ANM. SMR tests reduced the multiple hypothesis burdens by testing tens of thousands of genes instead of millions of SNPs \[[@pone.0213953.ref013]\]. It suggested that SMR was useful in identifying novel genes associated with AAM or ANM.

In this study, we identified 3 novel genes associated with AAM and 6 novel genes associated with ANM. One novel gene DDX5, which is also known as p68, was identified to be associated with ANM. DDX5 is a prototypic member of the DEAD box family of RNA helicases that encompasses multiple functions. DDX5 was highly expressed in a high proportion of breast cancers. Patients with a detectable level of both DDX5 and polo-like kinase-1 (pLK1) often had a poor prognosis \[[@pone.0213953.ref014]\].

In the significant loci, we redefined the functional genes which were more likely to play important roles in the process of menarche or natural menopause. We presented a list of genes to be followed up in future functional validation experiments. For example, HSD17B12 coding a 17beta-hydroxysteroid dehydrogenase transforms estrone (E1) into estradiol (E2) \[[@pone.0213953.ref015]\]. E2 is involved in the regulation of the estrous and menstrual female reproductive cycles. However, the previous study annotated the significant SNP to MIR129-2 ([Table 1](#pone.0213953.t001){ref-type="table"}). Fatty acid amide hydrolase (FAAH), the enzyme that breaks down the endocannabinoid anandamide and controls its levels, is regulated by estrogen \[[@pone.0213953.ref016]\]. The previous study annotated the significant SNP in this locus to RAD54L ([Table 2](#pone.0213953.t002){ref-type="table"}), however, we found that FAAH was more likely to be the causal gene in this locus. Another example is SRPK1, encoding the splicing factor kinase SRSF protein kinase 1, which was highly expressed in basal breast cancer cells \[[@pone.0213953.ref017]\]. The knockdown of SRPK1 significantly suppressed metastasis of breast cancer cells \[[@pone.0213953.ref018]\].

Despite the common belief that multiple genes are responsible for controlling the timing of menarche and natural menopause, very few genes have been identified that contain common genetic variants associated with AAM and ANM. In this study, we identified two genes (MSH6 and C11orf46) associated with both traits. rs3136249 is located in the intronic region of MSH6. MSH6, which is a mismatch repair gene, was found to be associated with ANM by the previous study \[[@pone.0213953.ref019]\]. The colorization analysis showed C11orf46 locus may be associated with both traits with the posterior probability of 0.79. This may be caused by the relatively large posterior probability of model 4 (0.21). However, the function of C11orf46 is unknown, further studies are needed to prove this result.

The present study may have some limitations that should be considered. Although we redefined the functional genes in the significant loci, these genes may be associated with age at natural menopause due to pleiotropy which meant that some of these genes may be not the causal genes. Due to the limitation of the method, we did not distinguish those pleiotropic genes from causal genes. So, further works are warranted to confirm the functional genes and explore the underlying mechanism.

In conclusion, we highlighted the putative functional genes in the significant loci for AAM and ANM. Our study prioritizes the associated genes for further functional mechanistic study of AAM and ANM and illustrates the benefit of integrating different omics data into the study of complex traits. Our study may help to understand the ovarian function and benefit for women's reproductive health.
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